Reducing impulsivity in repeat violent offenders: an open label trial of a selective serotonin reuptake inhibitor

Background: The association between serotonergic dysfunction and aggression hasprompted the use of selective serotonin re-uptake inhibitors (SSRIs) as a means of controllingimpulsive violent behaviour. The aim of the current study was to examine the feasibilityof using an SSRI to treat impulsivity i...

Full description

Bibliographic Details
Main Authors: Butler, Tony, Schofield, P., Greenberg, D., Allnut, S., Indig, D., Carr, V., D'Este, C., Mitchell, P., Knight, L., Ellis, A.
Format: Journal Article
Published: Taylor & Francis Ltd 2010
Subjects:
Online Access:http://hdl.handle.net/20.500.11937/11653
_version_ 1848747863747592192
author Butler, Tony
Schofield, P.
Greenberg, D.
Allnut, S.
Indig, D.
Carr, V.
D'Este, C.
Mitchell, P.
Knight, L.
Ellis, A.
author_facet Butler, Tony
Schofield, P.
Greenberg, D.
Allnut, S.
Indig, D.
Carr, V.
D'Este, C.
Mitchell, P.
Knight, L.
Ellis, A.
author_sort Butler, Tony
building Curtin Institutional Repository
collection Online Access
description Background: The association between serotonergic dysfunction and aggression hasprompted the use of selective serotonin re-uptake inhibitors (SSRIs) as a means of controllingimpulsive violent behaviour. The aim of the current study was to examine the feasibilityof using an SSRI to treat impulsivity in a group of repeat violent offenders.Methods: Potential participants were recruited from three magistrates ’ court complexes inthe Sydney metropolitan area and all had histories of violent offending (at least one priorconviction for a violent offence). Those who scored highly on the Barratt Impulsivity Scale(BIS-11), passed medical and psychiatric evaluations and consented to treatment wereprescribed sertraline (Zoloft) over a three month period.Results: Thirty-four individuals commenced the trial, with 20 completing the three month intervention.Reductions were observed across a range of behavioural measures from baseline to3 months: impulsivity (35%), irritability (45%), anger (63%), assault (51%), verbal-assault(40%), indirect-assault (63%), and depression (62%). All those who completed the three monthtrial requested to continue sertraline under the supervision of their own medical practitioner.Conclusion: Our fi ndings suggest that treating impulsive violent individuals in the criminaljustice system with an SSRI is a potential treatment opportunity for this population. Anadequately powered randomized control trial of this intervention is warranted.Key words: .
first_indexed 2025-11-14T06:55:55Z
format Journal Article
id curtin-20.500.11937-11653
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T06:55:55Z
publishDate 2010
publisher Taylor & Francis Ltd
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-116532017-02-28T01:33:31Z Reducing impulsivity in repeat violent offenders: an open label trial of a selective serotonin reuptake inhibitor Butler, Tony Schofield, P. Greenberg, D. Allnut, S. Indig, D. Carr, V. D'Este, C. Mitchell, P. Knight, L. Ellis, A. impulsivity Offenders selective serotonin re-uptake inhibitor Background: The association between serotonergic dysfunction and aggression hasprompted the use of selective serotonin re-uptake inhibitors (SSRIs) as a means of controllingimpulsive violent behaviour. The aim of the current study was to examine the feasibilityof using an SSRI to treat impulsivity in a group of repeat violent offenders.Methods: Potential participants were recruited from three magistrates ’ court complexes inthe Sydney metropolitan area and all had histories of violent offending (at least one priorconviction for a violent offence). Those who scored highly on the Barratt Impulsivity Scale(BIS-11), passed medical and psychiatric evaluations and consented to treatment wereprescribed sertraline (Zoloft) over a three month period.Results: Thirty-four individuals commenced the trial, with 20 completing the three month intervention.Reductions were observed across a range of behavioural measures from baseline to3 months: impulsivity (35%), irritability (45%), anger (63%), assault (51%), verbal-assault(40%), indirect-assault (63%), and depression (62%). All those who completed the three monthtrial requested to continue sertraline under the supervision of their own medical practitioner.Conclusion: Our fi ndings suggest that treating impulsive violent individuals in the criminaljustice system with an SSRI is a potential treatment opportunity for this population. Anadequately powered randomized control trial of this intervention is warranted.Key words: . 2010 Journal Article http://hdl.handle.net/20.500.11937/11653 Taylor & Francis Ltd restricted
spellingShingle impulsivity
Offenders
selective serotonin re-uptake inhibitor
Butler, Tony
Schofield, P.
Greenberg, D.
Allnut, S.
Indig, D.
Carr, V.
D'Este, C.
Mitchell, P.
Knight, L.
Ellis, A.
Reducing impulsivity in repeat violent offenders: an open label trial of a selective serotonin reuptake inhibitor
title Reducing impulsivity in repeat violent offenders: an open label trial of a selective serotonin reuptake inhibitor
title_full Reducing impulsivity in repeat violent offenders: an open label trial of a selective serotonin reuptake inhibitor
title_fullStr Reducing impulsivity in repeat violent offenders: an open label trial of a selective serotonin reuptake inhibitor
title_full_unstemmed Reducing impulsivity in repeat violent offenders: an open label trial of a selective serotonin reuptake inhibitor
title_short Reducing impulsivity in repeat violent offenders: an open label trial of a selective serotonin reuptake inhibitor
title_sort reducing impulsivity in repeat violent offenders: an open label trial of a selective serotonin reuptake inhibitor
topic impulsivity
Offenders
selective serotonin re-uptake inhibitor
url http://hdl.handle.net/20.500.11937/11653